Efficacy and safety of first-line immune checkpoint inhibitor–based combination therapy in metastatic renal cell carcinoma patients on hemodialysis.
| Publicado en: | Urologic Oncology Vol. 44; no. 9; pp. 451 - 460 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Elsevier B.V.
Sep2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=196297876&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 196297876 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10781439 JJ4 jtl: Urologic Oncology issn: 10781439 maglogo: N pubinfo: dt: Sep2026 vid: 44 iid: 9 pid: 467 pub: Elsevier B.V. place: New York, New York artinfo: ui: 196297876 10.1016/j.urolonc.2026.06.014 196297876 ppf: 451 ppct: 9 formats: tig: atl: Efficacy and safety of first-line immune checkpoint inhibitor–based combination therapy in metastatic renal cell carcinoma patients on hemodialysis. aug: au: Takahashi, Hidetsugu Fukuokaya, Wataru Yanagisawa, Takafumi Okamoto, Maria Urabe, Fumihiko Mori, Keiichiro Nishimura, Shingo Maenosono, Ryoichi Toyoda, Shingo Nukaya, Takuhisa Morinaka, Hirofumi Tamura, Keita Araki, Motoo Azuma, Haruhito Fujita, Kazutoshi Takahara, Kiyoshi Komura, Kazumasa Inamoto, Teruo Kimura, Takahiro affil: Department of Urology, The Jikei University School of Medicine, Tokyo, Japan sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|